Vera Therapeutics (VERA) EPS (Basic) (2020 - 2026)
Vera Therapeutics' (VERA) quarterly EPS (Basic) came in at -$4.03 in Q1 2026, down 314.54% YoY from $1.88 in Q1 2025, and down 78.87% on a QoQ basis from -$2.25 in Q4 2025.
Powered by 
Analysis
Vera Therapeutics (VERA) EPS (Basic) (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of EPS (Basic) data on file, last reported at -$4.03 in Q1 2026.
- Quarterly EPS (Basic) fell 314.54% year-over-year to -$4.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.49 (down 165.57% YoY) and the FY2025 annual result came in at $0.98, up 5419518.78% from the prior year.
- EPS (Basic) fell to -$4.03 in Q1 2026, from -$2.25 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.47 in Q2 2023 to a low of -$4.03 in Q1 2026.
- A 5-year average of -$1.18 and a median of -$0.9 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 96.08% — and 2026, when it tumbled 314.54%.
- Tracing VERA's EPS (Basic) over 5 years: stood at -$1.25 in 2022, then grew by 27.84% to -$0.9 in 2023, then advanced by 11.68% to -$0.8 in 2024, then tumbled by 182.71% to -$2.25 in 2025, then plunged by 78.87% to -$4.03 in 2026.
- The last three EPS (Basic) figures came in at -$4.03 (Q1 2026), -$2.25 (Q4 2025), and -$1.28 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Vera Therapeutics | 2.55 Bn | 2.55 Bn | - | -1.52 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.52 |
| Mar 31, 2026 | -1.69 |
| Dec 31, 2025 | -1.41 |
| Sep 30, 2025 | -1.26 |
| Jun 30, 2025 | -1.19 |
| Mar 31, 2025 | -0.82 |
| Dec 31, 2024 | -0.80 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.62 |
| Mar 31, 2024 | -0.57 |
| Dec 31, 2023 | -0.61 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.47 |
| Mar 31, 2023 | -0.81 |
| Dec 31, 2022 | -1.25 |
| Sep 30, 2022 | -0.91 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.71 |
| Dec 31, 2021 | -1.24 |
| Sep 30, 2021 | -0.34 |